Shandong Pharmaceutical GlassLtd Future Growth
Future criteria checks 2/6
Shandong Pharmaceutical GlassLtd is forecast to grow earnings and revenue by 19.5% and 14% per annum respectively. EPS is expected to grow by 19.1% per annum. Return on equity is forecast to be 13.4% in 3 years.
Key information
19.5%
Earnings growth rate
19.1%
EPS growth rate
Medical Equipment earnings growth | 26.4% |
Revenue growth rate | 14.0% |
Future return on equity | 13.4% |
Analyst coverage | Good |
Last updated | 29 Oct 2024 |
Recent future growth updates
No updates
Recent updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 7,095 | 1,378 | N/A | 1,542 | 7 |
12/31/2025 | 6,288 | 1,186 | N/A | 1,384 | 8 |
12/31/2024 | 5,912 | 1,028 | N/A | 856 | 1 |
9/30/2024 | 5,133 | 882 | 596 | 1,134 | N/A |
6/30/2024 | 5,146 | 865 | 642 | 1,221 | N/A |
3/31/2024 | 5,013 | 830 | 459 | 1,134 | N/A |
12/31/2023 | 4,982 | 776 | 376 | 1,048 | N/A |
9/30/2023 | 4,872 | 738 | 82 | 781 | N/A |
6/30/2023 | 4,633 | 682 | -131 | 556 | N/A |
3/31/2023 | 4,382 | 632 | -99 | 502 | N/A |
12/31/2022 | 4,187 | 618 | -458 | 252 | N/A |
9/30/2022 | 4,058 | 616 | -277 | 548 | N/A |
6/30/2022 | 4,040 | 612 | -112 | 674 | N/A |
3/31/2022 | 3,991 | 588 | 25 | 773 | N/A |
12/31/2021 | 3,875 | 591 | -59 | 750 | N/A |
9/30/2021 | 3,921 | 620 | -55 | 676 | N/A |
6/30/2021 | 3,703 | 603 | -206 | 551 | N/A |
3/31/2021 | 3,592 | 585 | -243 | 445 | N/A |
12/31/2020 | 3,427 | 564 | 31 | 566 | N/A |
9/30/2020 | 3,147 | 532 | -6 | 498 | N/A |
6/30/2020 | 3,093 | 503 | 89 | 594 | N/A |
3/31/2020 | 3,042 | 484 | -53 | 596 | N/A |
12/31/2019 | 2,992 | 459 | 7 | 599 | N/A |
9/30/2019 | 2,821 | 437 | -87 | 546 | N/A |
6/30/2019 | 2,720 | 409 | -31 | 493 | N/A |
3/31/2019 | 2,651 | 386 | 124 | 492 | N/A |
12/31/2018 | 2,585 | 358 | 118 | 466 | N/A |
9/30/2018 | 2,546 | 326 | 245 | 485 | N/A |
6/30/2018 | 2,481 | 298 | N/A | 446 | N/A |
3/31/2018 | 2,400 | 281 | N/A | 349 | N/A |
12/31/2017 | 2,330 | 263 | N/A | 412 | N/A |
9/30/2017 | 2,314 | 259 | N/A | 349 | N/A |
6/30/2017 | 2,236 | 236 | N/A | 423 | N/A |
3/31/2017 | 2,181 | 216 | N/A | 461 | N/A |
12/31/2016 | 2,057 | 190 | N/A | 507 | N/A |
9/30/2016 | 1,860 | 162 | N/A | 478 | N/A |
6/30/2016 | 1,801 | 159 | N/A | 446 | N/A |
3/31/2016 | 1,758 | 152 | N/A | 465 | N/A |
12/31/2015 | 1,723 | 145 | N/A | 390 | N/A |
9/30/2015 | 1,771 | 141 | N/A | 440 | N/A |
6/30/2015 | 1,771 | 130 | N/A | 341 | N/A |
3/31/2015 | 1,717 | 127 | N/A | 293 | N/A |
12/31/2014 | 1,691 | 125 | N/A | 267 | N/A |
9/30/2014 | 1,653 | 117 | N/A | 282 | N/A |
6/30/2014 | 1,599 | 122 | N/A | 260 | N/A |
3/31/2014 | 1,577 | 121 | N/A | 286 | N/A |
12/31/2013 | 1,545 | 122 | N/A | 269 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 600529's forecast earnings growth (19.5% per year) is above the savings rate (2.9%).
Earnings vs Market: 600529's earnings (19.5% per year) are forecast to grow slower than the CN market (25% per year).
High Growth Earnings: 600529's earnings are forecast to grow, but not significantly.
Revenue vs Market: 600529's revenue (14% per year) is forecast to grow faster than the CN market (13.9% per year).
High Growth Revenue: 600529's revenue (14% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 600529's Return on Equity is forecast to be low in 3 years time (13.4%).